Product Information
CHOLESTYRAMINE LIGHT PACKET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.8327 per EA under NDC 68382052960. Its NADAC has been published 440 times since Apr 4, 2018.
FDA first approved this application on Apr 25, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 g/5.5g
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382052960
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CHOLESTYRAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA202902FDA Approved
4/25/2017
TE Code
AB
On Market Since
6/8/2017
Pharmacological Classes
Price Statistics
The NADAC for CHOLESTYRAMINE LIGHT PACKET has been published 440 times since Apr 4, 2018, and over the history we have for it it has declined 55.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8327 per EA |
|---|---|
| All-time high | $1.8879 (Apr 11, 2018) |
| All-time low | $0.7336 (Apr 17, 2024) |
| 52-week high | $0.9002 |
| 52-week low | $0.7955 |
| Median price | $1.1860 |
| Average price | $1.1837 |
| Largest weekly change | +21.4% (Jun 19, 2024) |
| Weeks tracked | 440 |
| Tracking since | Apr 4, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CHOLESTYRAMINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bile Acid Sequestrant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHOLESTYRAMINE LIGHT PACKET?
The current National Average Drug Acquisition Cost (NADAC) for CHOLESTYRAMINE LIGHT PACKET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.8327 per EA (NDC 68382052960), effective Sep 30, 2026.
How has the price of CHOLESTYRAMINE LIGHT PACKET changed over time?
Over the history we have for it, the NADAC for CHOLESTYRAMINE LIGHT PACKET has declined 55.9%. It has been tracked across 440 weekly CMS publications since Apr 4, 2018.
What are the highest and lowest recorded NADAC prices for CHOLESTYRAMINE LIGHT PACKET?
Since Apr 4, 2018, the NADAC for CHOLESTYRAMINE LIGHT PACKET has ranged from a low of $0.7336 (Apr 17, 2024) to a high of $1.8879 (Apr 11, 2018), with a median of $1.1860 per EA.
Are there cheaper alternatives to CHOLESTYRAMINE LIGHT PACKET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CHOLESTYRAMINE LIGHT PACKET in a comparable dosage form, but none are currently priced below it.
Who manufactures CHOLESTYRAMINE LIGHT PACKET?
CHOLESTYRAMINE LIGHT PACKET (NDC 68382052960) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.